Woman Drug-induced Lupus to Advance Claims Against Medicis Pharmaceutical Corporation

Published Date : Feb 03, 2015

A woman having lupus from Arizona  is planning to advance her claims against a drugmaker for failing to tell her about the risks involved with the long-term use of acne medication Solodyn.

Amanda Watts had filed the case against the Scottsdale-based pharmacy company Medicis Pharmaceutical Corporation in 2012 in Superior Court of Maricopa Country. She claimed that the pharmacy company has not notified her that the long term use of Solodyn could induce a risk of autoimmune syndromes, autoimmune hepatitis, drug-induced lupus, serum sickness and vasculitis.

It is being said that Watts was diagnosed with drug-induced hepatitis and drug-induced lupus, diseases she blames due to her use of Solodyn. Through Watts had recovered from hepatitis, she still suffers from lupus, a condition that may last for all her life. 

Watts told the court that she took the prescribed dose of Solodyn for a complete 20 weeks period in 2008. She repeated the course for another 20 weeks in 2010 for treating chronic. Watts says that the literature she received about the medicine did not mention anything about such autoimmune side-effects.

The full prescribing information of Solodyn does issue the warning that prolonged use of minocycline, Solodyn’s active ingredient, may result in autoimmune hepatitis and lupus-like syndromes, Watts states that she never received any such information.

Watts’ claims for product liability and consumer fraud were dismissed by the court, but a unanimous review of the case was undertaken by an appellate panel. According to the ruling, Medicis failed to influence the court with its plea that prescription drugs are not merchandises and that their use should always be made through a legal prescription. 

The court said to the three-person panel that although medical professionals issue prescriptions for consumers so they can purchase certain drugs, consumers may rule their own preferences based on how the medication is advertised. So, consumers may be deceived by wrongful interpretations of prescription drugs just as in the case of consumer goods.